UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Tectonic Advisors LLC

Tectonic Advisors LLC lowered its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 36.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 732 shares of the healthcare conglomerate’s stock after selling 427 shares during the period. Tectonic Advisors LLC’s holdings in UnitedHealth Group were worth $370,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of the company. M&T Bank Corp boosted its stake in UnitedHealth Group by 13.4% during the third quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate’s stock worth $128,975,000 after buying an additional 26,074 shares during the period. Sugarloaf Wealth Management LLC raised its position in UnitedHealth Group by 17.6% in the fourth quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate’s stock valued at $4,025,000 after purchasing an additional 1,193 shares during the period. Benjamin Edwards Inc. boosted its position in shares of UnitedHealth Group by 1,275.3% during the third quarter. Benjamin Edwards Inc. now owns 44,547 shares of the healthcare conglomerate’s stock worth $26,060,000 after buying an additional 41,308 shares during the period. Parsifal Capital Management LP acquired a new position in UnitedHealth Group during the 3rd quarter worth about $21,165,000. Finally, Signal Advisors Wealth LLC increased its stake in UnitedHealth Group by 13.0% during the fourth quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate’s stock worth $4,611,000 after purchasing an additional 1,051 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the stock in a transaction that occurred on Friday, January 17th. The shares were acquired at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. The trade was a 28.57 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 0.33% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have commented on the stock. Stephens boosted their price target on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research note on Thursday, December 5th. Royal Bank of Canada lowered their target price on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research note on Wednesday, October 16th. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price for the company in a research note on Friday, January 10th. Finally, Truist Financial cut their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a report on Monday, January 6th. One equities research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Buy” and a consensus target price of $629.32.

UnitedHealth Group Stock Performance

Shares of UNH opened at $529.71 on Friday. The stock has a market capitalization of $487.48 billion, a P/E ratio of 34.17, a P/E/G ratio of 1.48 and a beta of 0.61. The company’s fifty day moving average is $532.43 and its two-hundred day moving average is $564.77. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same quarter in the previous year, the company earned $5.83 EPS. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.63 earnings per share for the current year.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.